3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
8
Neoplasms
4
Colorectal Neoplasms
4
Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Precancerous Conditions
2
Male Urogenital Diseases
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Vascular Diseases
1
Thrombocytopenia
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphedema
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Exercise
4
Walking
2
Memantine
2
Donepezil
2
beta Carotene
1
Vitamin E
1
Ultraviolet Therapy
1
Time
1
Tai Ji
1
Surveys and Questionnaires
1
Sugars
1
Standard of Care
1
Sirolimus
1
Riluzole
1
Rehabilitation, Vocational
1
Referral and Consultation
1
Ramipril
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Population Groups
1
Pioglitazone
1
Palliative Care
1
Neuropsychological Tests
1
Mindfulness-Based Stress Reduction
1
Methods
1
Interviews as Topic
1
Ibuprofen
1
Hormones
1
Hematologic Tests
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cognitive Dysfunction
×
Vitamin E
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled